S. Lee

Minimal residual disease-based effect and long-term outcome of first-line dasatinib combined with chemotherapy for adult Philadelphia chromosome-positive acute lymphoblastic leukemia

J.-H. Yoon, Ho‐Young Yhim, Jae‐Yong Kwak et al. · Annals of Oncology · 2016 · 61 citations · Full text

Medicine, Hematology, Oncology +16

Immune microenvironment and lymph node yield in colorectal cancer

S. Lee, Amaya Pankaj, Azfar Neyaz et al. · British Journal of Cancer · 2023 · 24 citations · Full text

Medicine, Immunology, Oncology +16

Elevated interleukin-32 expression in granulomatosis with polyangiitis

Seongman Bae, Yong‐Gil Kim, Jene Choi et al. · Lara D. Veeken · 2012 · 21 citations

Veterinary Medicine, Immunology, Pathology +15

Bortezomib in Combination with Conventional Chemotherapeutic Agents for Multiple Myeloma Compared with Bortezomib Alone

Chang‐Ki Min, M.-J. Lee, Ki‐Seong Eom et al. · Japanese Journal of Clinical Oncology · 2007 · 18 citations · Full text

Medicine, Oncology, Pharmacology +17

OA10.05 An Open-Label, Multicenter, Phase II Single Arm Trial of Osimertinib in NSCLC Patients with Uncommon EGFR Mutation(KCSG-LU15-09)

J.H. Cho, Jong‐Mu Sun, S. Lee et al. · Journal of Thoracic Oncology · 2018 · 16 citations · Full text

Medicine, Oncology, Pharmacotherapy +8